Georgios Laliotis

14PUBLICATIONS
88CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 19, 2025
Investigating Early Kinetics in Plasma ctDNA and Peripheral T-cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Squamous Cell Carcinoma.

Enrique Sanz-Garcia, Shirin Soleimani, Jeff P Bruce

|Sep 24, 2025
Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.

Rebecca Hassoun, Reuben Ben-David, John P Sfakianos

|Aug 11, 2025
Tumor-Informed ctDNA Assay to Predict Outcome in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with PD-1 Inhibitor.

Natasha Honoré, George Laliotis, Vasily N Aushev

|Jul 24, 2025
Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker study.

Aziz Zaanan, Audrey Didelot, Chloé Broudin

|Mar 21, 2025
Circulating Tumor DNA Assessment to Predict Risk of Recurrence After Surgery in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational Study.

Shogo Takei, Daisuke Kotani, George Laliotis

|Oct 02, 2023
Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up.

Sia V Lindskrog, Karin Birkenkamp-Demtröder, Iver Nordentoft

Pageof 3

Frequent Collaborators

6 joint publications

Minetta Liu

5 joint publications

Philip N Tsichlis

5 joint publications

Lalit Sehgal

4 joint publications

Vincenzo Coppola